Ind B : Publication le 03/10/2014
11/09/2026 : Update of the dossier following the change in the formulation of EPODUX 209 Base due to regulatory changes concerning certain oxirane compounds. Dedicated testing campaign validated that the reformulated version does not result in any performance regression.
Diluent 67-232v02.-V02 has received an orange CMR hazard warning due to the presence of ethylbenzene, a substance classified as possibly carcinogenic (Category 2B) by the IARC. Please be aware of the risk of exposure to mists/aerosols in the event of spraying, as well as the risk of exposure to dust when handling the dried product